It’s well known that #mammography alone is considered an ineffective method for #breast #cancer #surveillance and diagnosing cancer recurrence, but from now on this statement is #outdated. #Radiodiagnosis Department at Kasr AlAiny School of Medicine, Cairo University, in collaboration with Baheya Foundation for early breast cancer and treatment, performed a #pioneer study in the field of #breast #imaging that aimed to evaluate the ability to use #artificial #intelligence (AI) for reading digital mammograms to #exclude #recurrence in the #operative bed of known breast cancer following the different surgical procedures: #lumpectomy, #quadrantectomy, #oncoplastic_surgery, and #reconstructive_surgeries (post-mastectomy) presented by #autologous_tissue_flaps or #prosthetic_implants. The AI scoring percentage for a clear operative bed ranged from 0% to 26%, with a mean of 15%. Operative bed benign changes displayed a score range from 10% to 88%, mean 48.2%, and malignancy recurrence range from 65% to 99%, mean 87.7%. The optimum cut-off #value to distinguish between benign postoperative changes and malignancy recurrence was 56.5% (95%, CI 0.824–1.060, p value <0.001). #Reconstructive surgeries with autologous #implants showed a range AI scoring of 19.6% to 14.7%, for intact implants. Implants that showed #intracapsular_rupture -confirmed by MR imaging- displayed a score range of 45% to 67%, and a mean of 58.7% + 11.9%. Further investigations yet to come involving AI and integrity of silicone implants. Methods: Lunit Cancer Screening AI-MMG, on digital mammography. Dual-energy contrast-enhanced mammography unit; *Amulet Innovality (FUJIFILM Healthcare Middle East & Africa Global Company, Japan) and *Senographe Pristina 3D machine (GE HealthCare, United Kingdom). #digitalmammography, #artificialintelligence #breastcancer #suspiciouslesions, #cancer_recurrance #post_operative_changes, #reconstructive_breast_surgeries
Sahar Mansour的动态
最相关的动态
-
March is Colorectal Cancer Awareness Month. The second leading cause of cancer death in the United States today is colorectal cancer, and approximately 150,000 people in the US will be diagnosed with the disease this year. The Vattikuti Foundation applauds robotic surgeons like Dr. Somashekhar SP, Dr. Kushal Agrawal, and the team from Aster International Institute of Oncology, Aster Hospital who have found ways to preserve nerve functionality for patients undergoing surgery for colorectal cancer. Surgical methods in the past commonly resulted in a high incidence of organ dysfunction, which severely compromised patient quality of life with complications such as low anterior rectal (LAR) syndrome and urogenital dysfunctions due to intraoperative inadvertent pelvic autonomic nerve damage after rectal cancer surgery. In their video submitted for KS International Innovation Awards 2023, the team from Aster Hospital discusses the current understanding of anatomy, key zones at risk of nerve injury and our experience with robotic platform in rectal surgery. Open call to innovative colorectal robotic surgeons: now's the time to prepare a video with your successful and innovative ways of using technology to help patients beat colorectal surgery. Your 8-minute electronic submission can be entered in the KS International Innovation Awards 2024 competition beginning April 15, 2024. Here is the link to the surgical video: https://lnkd.in/damNmg9Q Dr Kushal Agrawal Aster DM Healthcare ASTER MEDCITY Dr. Somashekhar S P Raj Vattikuti Mahendra Bhandari #colorectalcancer #colorectalcancerawareness #colorectal #roboticsurgeon #roboticsurgery #Surgery #surgeons #robotics #roboticschallenge #roboticsinnovation #KSAwards2024 #vattikutifoundation
要查看或添加评论,请登录
-
You 'can' cure CANcer ! ( Early lung cancer management ) 45 year female, non smoker Complaints: Cough, loss of weight and appetite PET CT Chest: Nodule - 2.7 * 2.5 cms in right lower lobe Referred for evaluation and management Plan : Radial EBUS + Cryobiopsy of nodule Radial EBUS: Eccentric image Imprint the RB10 subsegment Linear EBUS introduced into RB10 sub segment and rotated 180 degree - Visualisation of nodule Intratumoral cryobiopsy done Imprint cytology : Atypical cells Intranodal cryobiopsy : Adenocarcinoma Staging EBUS : Negative mediastenal lymphnode stations TNM : ( T1c, N0, M0 ) Stage : 1A3 Robotic VATS lobectomy done Learning points : 1. Linear EBUS can be tried for lesions with Eccentric images in Radial EBUS even those involving sub segmental bronchus ( Index case - Lesion Localised to RB10 ) Advantages : - Biopsy under direct vision - Less chance of airway bleeding - Tamponade effect of mass - Allows simultaneous lymphnode Staging Department of Interventional Pulmonology & Thoracic surgery Yashoda Hospitals , Somajiguda, Hyderabad Erbe Group Amol Patil Dr. Nitika Sharma FUJIFILM India Endoscopy Balu Mahendran Subramanian Dheeraj Chaudhri
要查看或添加评论,请登录
-
A 58-year-old male presented with a 2-month history of hoarseness, left tonsillar swelling, and headaches. Clinical examination revealed a visible left tonsillar mass intraorally, with no external neck swelling. MRI angiography initially suggested a Type 3B carotid tumor, indicating possible internal carotid artery (ICA) encasement or a vagus/hypoglossal nerve schwannoma. Due to the complexity of the case, we planned a transcervical excision of the parapharyngeal tumor, with contingencies for ICA resection and Dacron graft placement if needed, with vascular surgery team backup. We also considered a mandibulotomy for enhanced exposure, if required. Intraoperatively, however, we found that the ICA was only partially encased rather than fully encased, as the imaging reports had indicated. This allowed us to successfully dissect the tumor from the ICA without injury. Additionally, this was not a carotid body tumor but a large mass extending from just above the carotid bifurcation up to the skull base, reaching beyond the C1 vertebra, and positioned laterally to the carotid artery. The tumor was tightly adherent at the carotid canal, with the vagus nerve enveloped by the mass. After carefully releasing it from the?carotid canal, we successfully delivered the tumor, thus negating the need for a mandibulotomy. All major vessels, including the carotids, internal and external jugular veins, were preserved, as well as the hypoglossal and spinal accessory nerves. As the vagus nerve was engulfed by the tumor, it was sacrificed. Dr. Vishal Vora, our plastic surgeon, performed a microneural anastomosis using a cable graft from the greater auricular nerve. Postoperatively, the patient demonstrated an excellent outcome, with a well-compensated vocal cord on endoscopy, minimal voice changes, and no aspiration issues. He was discharged in stable condition on the third postoperative day and is expected to achieve full recovery within a month. This case underscores the importance of precise surgical planning and adaptability, as intraoperative findings can often challenge preoperative imaging. Our multidisciplinary approach allowed us to achieve a successful outcome while preserving vital structures. - This case was performed by Dr.Bhavin Vadodariya of SSO Team Ahmedabad. #cancer #headandneckcancer #cancercare #Cancercure #cancertreatment #cancerpatients #cancerdoctors #multidisciplinary #operation #canceroperation #surgicalplanning #cancerhospital #hospital #oncosurgeon #hospitals #doctors #oncology
要查看或添加评论,请登录
-
What are the advancements and availability of robotic cancer surgeon in India? #drsurenderdabas.com?#roboticcancer?#bestroboticcancer?#roboticcancersugeon?#roboticsurgery?#roboticsurgeon Introducing: Dr. Surender Dabas: Pioneering Excellence in Robotic Cancer Surgeon in India Welcome to the forefront of medical innovation, where precision meets compassion — introducing Dr. Surender Dabas, a trailblazer in the realm of robotic cancer surgery in India. Driven by a relentless commitment to advancing healthcare, Dr. Dabas seamlessly combines cutting-edge technology with unparalleled expertise to redefine the landscape of cancer treatment. Imagine a future where the fight against cancer is not just a battle but a surgical masterpiece. Dr. Surender Dabas brings this vision to life through his groundbreaking work in robotic cancer surgery, heralding a new era in medical excellence. Harnessing the power of state-of-the-art robotic systems, every procedure becomes a symphony of precision, ensuring minimal invasiveness and faster recovery for patients. Dr. Dabas stands as a beacon of hope for those facing the daunting prospect of cancer, offering a personalized approach that combines technology and compassion. Frequently Asked Questions (FAQs): Q1: What is robotic cancer surgery, and how does it differ from traditional methods? 1: Robotic cancer surgery is an advanced technique that utilizes robotic systems to enhance the precision and efficiency of surgical procedures. Unlike traditional methods, robotic surgery allows for smaller incisions, reduced blood loss, and quicker recovery times, offering patients a minimally invasive alternative with improved outcomes. Q2: Why choose Dr. Surender Dabas for robotic cancer surgery in India? 2: Dr. Surender Dabas is a pioneer in the field, combining extensive experience with a commitment to embracing the latest technological advancements. His personalized approach ensures that each patient receives the highest standard of care, with a focus on achieving optimal results and minimizing the impact on their quality of life. Q3: Are robotic surgeries safe, and what are the benefits for cancer patients? 3: Yes, robotic surgeries are considered safe when performed by skilled and experienced surgeons like Dr. Surender Dabas. The benefits for cancer patients include reduced postoperative pain, shorter hospital stays, quicker recovery, and improved precision in removing cancerous tissues. Q4: How can patients schedule a consultation with Dr. Surender Dabas for robotic cancer surgery? 4: Patients can easily schedule a consultation by contacting Dr. Surender Dabas’s office through the official website or by reaching out to the dedicated patient care team. The initial consultation provides an opportunity for patients to discuss their case, ask questions, and explore the potential benefits of robotic cancer surgeon in India.
要查看或添加评论,请登录
-
Can you recommend the first class? best robotic cancer surgeon in India for advanced and effective treatment? #drsurenderdabas.com #roboticcancer #bestroboticcancer #roboticcancersugeon #roboticsurgery #roboticsurgeon Introducing: Dr. Surender Dabas: Pioneering Excellence in Robotic Cancer Surgery in India Embark on a revolutionary journey towards advanced and precise cancer care with Dr. Surender Dabas, the beacon of innovation in best robotic cancer surgeon in India. Renowned for his unwavering commitment to patient well-being and cutting-edge medical techniques, Dr. Dabas stands as a trailblazer in the field, consistently delivering unparalleled results through state-of-the-art robotic surgical interventions. About Dr. Surender Dabas: With a stellar reputation as the best robotic cancer surgeon in India, Dr. Surender Dabas brings forth a wealth of experience and expertise. His dedication to incorporating the latest technological advancements, particularly in robotic-assisted surgeries, has elevated him to the forefront of cancer care. Dr. Dabas envisions a future where precision meets compassion, redefining the landscape of oncological interventions. Cutting-Edge Robotic Technology: Frequently Asked Questions (FAQs): Q1: What makes Dr. Surender Dabas the best robotic cancer surgeon in India? 1: Dr. Dabas combines extensive experience with a pioneering spirit, utilizing state-of-the-art the best robotic cancer surgeon in India to achieve unprecedented precision in cancer surgeries. His commitment to patient-centric care sets him apart in the field. Q2: What are the advantages of robotic-assisted cancer surgery? 2: Robotic surgery offers minimally invasive procedures, resulting in smaller incisions, reduced pain, faster recovery, and enhanced precision. Dr. Dabas leverages these benefits to optimize patient outcomes and improve overall quality of life. Q3: How does Dr. Dabas ensure personalized care for each patient? 3: Dr. Surender Dabas takes a personalized approach to cancer care, tailoring treatment plans to each patient’s unique needs. His empathetic approach, combined with cutting-edge technology, ensures a comprehensive and compassionate healing journey. Q4: What types of cancer surgeries does Dr. Dabas specialize in? 4: Dr. Dabas specializes in a wide range of cancer surgeries, utilizing robotic technology for procedures related to prostate, colorectal, gynecological, and urological cancers, among others. His diverse expertise ensures comprehensive care across various malignancies. Q5: How can I schedule a consultation with Dr. Surender Dabas? 5: To schedule a consultation with Dr. Dabas, please visit our website at drsurenderdabas or contact our dedicated patient care team. We are committed to providing prompt and accessible healthcare services.
Robotic Cancer Surgeon In India
drsurenderdabas.com
要查看或添加评论,请登录
-
EUBREAST-01 (GBG 104) Study: De-Escalating Surgery for Triple-Negative and HER2-Positive Breast Cancer Patients The #EUBREAST01 trial explores the possibility of omitting #sentinel #lymph #node #biopsy in #patients with triple-negative or #HER2-positive breast cancer who have achieved a complete radiological and pathological response in the breast after #neoadjuvant systemic therapy (#NAST). ?? Study Design: This is a prospective, non-randomized, single-arm surgical trial. Patients who show no signs of residual disease in the breast after therapy may skip #axillary #surgery entirely, including sentinel lymph node #biopsy, helping to reduce the invasiveness of treatment. Supported by the ELSE KRONER-FRESENIUS STIFTUNG and the EUBREAST Network, this study is aimed at transforming surgical approaches for breast cancer patients with high response rates to systemic therapy. The Study Chairs are Prof. Toralf Reimer (Rostock) and Dr. Oreste Davide Gentilini (Milan). ?? Status: The #trial began recruitment in January 2021 and is currently enrolling patients. Find more information here: https://lnkd.in/eXmKGRF3 GBG Forschungs GmbH #BreastCancerResearch #EUBREAST01 #GBG #HER2Positive #TripleNegative #DeEscalation #BreastCancerAwareness
要查看或添加评论,请登录
-
Prof. Kim and Prof. Choi's groundbreaking research on dual-channel near-infrared fluorescence for precise pulmonary segmentectomy marks a significant advancement in lung cancer surgery. This innovative technique allows for accurate visualization of cancer margins and intersegmental lines, leading to improved outcomes and quality of life for patients. The stability and safety of the fluorescence agents used in the study demonstrate great potential for clinical application in cancer surgeries beyond lung cancer. The collaboration between Korea University's Guro Hospital and Harvard Medical School highlights the importance of international research partnerships in advancing medical innovation. #medicalresearch #cancertreatment #lungcancer #surgeryinnovation #fluorescenceimaging
Dual-channel fluorescence imaging for precise and safe pulmonary segmentectomy
medicalxpress.com
要查看或添加评论,请登录
-
More positive news for lung cancer patients. ALK+ UK’s chair and founder, Debra Montague, is enrolled in a pioneering trial into robotic lung cancer treatment led by Professor Pallav Shah at the Royal Brompton Hospital. This innovative procedure integrates diagnosis and treatment into a single session, utilising robotic technology for unparalleled precision. With a robot-guided catheter and advanced 3D lung mapping, this method efficiently and safely targets and eradicates tumours, reducing treatment times and minimising surgical risks. This breakthrough offers new hope and could transform lung cancer care, especially for patients ineligible for traditional surgery. #LungCancer #RoboticSurgery #NSCLC #ALKPositiveLungCancer
要查看或添加评论,请登录
-
??Happy to share with you my published case on #eurorad European Society of Radiology ??Intestinal nonrotation in an adult with colon cancer?? CHIRAZ JEMLI CHAMMAKHI https://lnkd.in/dQFY8Mbh This case raises two interesting points: - is intestinal malrotation a risk factor for digestive cancer ? - is it necessary to do screening in patients diagnosed at a young age with intestinal malrotation ? #case #casereport #radiology #abdominal #imaging
Eurorad.org
eurorad.org
要查看或添加评论,请登录
-
An international team of medics, scientists and researchers have designed an AI tool that can indicate how likely a patient is to experience problems after surgery and radiotherapy. The technology, being trialled in the UK, France and the Netherlands, could help patients access more personalised care. Dr Tim Rattay, a consultant breast surgeon and associate professor at the University of Leicester, highlights the importance of this tool in managing the side-effects of breast cancer treatment. Skin changes, scarring, lymphoedema, and even heart damage from radiation treatment can be debilitating for patients, but this AI tool can help predict and manage these side-effects. Read more about this exciting development here: https://lnkd.in/dXHtdG2x #BreastCancer #AIinHealthcare #PersonalizedCare
Medics design AI tool to predict side-effects in breast cancer patients
theguardian.com
要查看或添加评论,请登录
Professor of Radiology, Women's imaging unit, Kasr ElAiny Hospital, Cairo University. Cairo, Egypt.
5 个月It's a great achievement, no work has been carried out in Egypt or the Middle East on such issue to date.